Suppr超能文献

相似文献

1
Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones.
J Physiol. 2005 Nov 15;569(Pt 1):209-21. doi: 10.1113/jphysiol.2005.095554. Epub 2005 Sep 1.
2
NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones.
J Physiol. 2008 Feb 1;586(3):739-50. doi: 10.1113/jphysiol.2007.144618. Epub 2007 Nov 22.
3
Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.
Eur J Neurosci. 2010 Aug;32(3):359-67. doi: 10.1111/j.1460-9568.2010.07298.x. Epub 2010 Jul 6.
4
Subtypes of NMDA receptors in new-born rat hippocampal granule cells.
J Physiol. 2002 May 15;541(Pt 1):41-64. doi: 10.1113/jphysiol.2001.014001.
5
Identification of subunits contributing to synaptic and extrasynaptic NMDA receptors in Golgi cells of the rat cerebellum.
J Physiol. 2000 Apr 1;524 Pt 1(Pt 1):147-62. doi: 10.1111/j.1469-7793.2000.00147.x.
6
Molecular determinants of NMDA receptor function in GABAergic neurones of rat forebrain.
J Physiol. 1997 Feb 15;499 ( Pt 1)(Pt 1):47-63. doi: 10.1113/jphysiol.1997.sp021910.
7
Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
J Pharmacol Exp Ther. 2007 Aug;322(2):721-9. doi: 10.1124/jpet.107.122036. Epub 2007 May 11.
10
Incremental conductance levels of GABAA receptors in dopaminergic neurones of the rat substantia nigra pars compacta.
J Physiol. 1999 May 1;516 ( Pt 3)(Pt 3):719-37. doi: 10.1111/j.1469-7793.1999.0719u.x.

引用本文的文献

1
NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies.
Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.
2
Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor.
Neuron. 2025 Apr 2;113(7):991-1005.e5. doi: 10.1016/j.neuron.2025.01.013. Epub 2025 Feb 14.
3
Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.
Methods Mol Biol. 2024;2799:55-77. doi: 10.1007/978-1-0716-3830-9_5.
4
Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.
J Neurosci. 2023 Nov 15;43(46):7730-7744. doi: 10.1523/JNEUROSCI.1955-22.2023. Epub 2023 Sep 19.
5
Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.
Int J Mol Sci. 2023 Jul 23;24(14):11835. doi: 10.3390/ijms241411835.
6
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.
Neuropsychopharmacology. 2024 Jan;49(1):51-66. doi: 10.1038/s41386-023-01614-3. Epub 2023 Jun 27.
7
Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders.
Front Mol Neurosci. 2023 May 18;16:1193590. doi: 10.3389/fnmol.2023.1193590. eCollection 2023.
8
Function of Excitatory Periaqueductal Gray Synapses in the Ventral Tegmental Area following Inflammatory Injury.
eNeuro. 2022 Dec 22;9(6). doi: 10.1523/ENEURO.0324-22.2022. Print 2022 Nov-Dec.

本文引用的文献

1
Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
Neuron. 2005 Apr 21;46(2):261-74. doi: 10.1016/j.neuron.2005.03.005.
2
The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.
J Neurosci. 2005 Jan 12;25(2):308-17. doi: 10.1523/JNEUROSCI.3967-04.2005.
3
NR2 subunit-dependence of NMDA receptor channel block by external Mg2+.
J Physiol. 2005 Jan 15;562(Pt 2):319-31. doi: 10.1113/jphysiol.2004.076737. Epub 2004 Oct 28.
4
Role of distinct NMDA receptor subtypes at central synapses.
Sci STKE. 2004 Oct 19;2004(255):re16. doi: 10.1126/stke.2552004re16.
5
Rationale for and use of NMDA receptor antagonists in Parkinson's disease.
Pharmacol Ther. 2004 May;102(2):155-74. doi: 10.1016/j.pharmthera.2004.04.001.
8
Subtypes of NMDA receptors in new-born rat hippocampal granule cells.
J Physiol. 2002 May 15;541(Pt 1):41-64. doi: 10.1113/jphysiol.2001.014001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验